Johnson & Johnson
(BSP:JNJB34)
R$
60.12
0 (0%)
Market Cap: 2.18 Til
Enterprise Value: 2.27 Til
PE Ratio: 24.52
PB Ratio: 5.08
GF Score: 76/100 Johnson & Johnson at Cowen Health Care Conference Transcript
Mar 07, 2023 / 04:10PM GMT
Release Date Price:
R$53.16
(-0.32%)
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst
Okay. Good morning. I'm Josh Jennings, Cowen Medical Devices team. We're moving right through the medical devices track, but we are incorporating some medical device part of a consumer hybrid into this track. And thankfully, with the executive team from Johnson & Johnson, we have Executive Vice President and Chief Financial Officer, Joe Wolk; and Vice President of Investor Relations, Jessica Moore. Joe, Jessica. Josh, we got 3 Js up here. Can't lose. Can't lose.
Thank you guys for participating in Cowen Healthcare -- TD Cowen Healthcare Conference, and great to see you in person.
Joseph J. Wolk
Johnson & Johnson - Executive VP & CFO
Same here. Thanks, Josh, for having us.
Questions & Answers
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst
Maybe to start, I just wanted to talk about some of the headwinds. I know Johnson & Johnson reports first, at least in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot